Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease
- PMID: 16687179
- DOI: 10.1016/j.antiviral.2006.03.015
Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease
Abstract
Peptides based on the amino (N) and carboxy (C)-terminal regions of human immunodeficiency virus type-1 (HIV-1) protease and on the C-terminus of p6* can inhibit HIV-1 protease activity by preventing dimerization. We developed a peptide dimerization inhibitor, P27, that included these domains and a cell permeable domain derived from HIV-1 Tat. P27 inhibited wild type (WT) and protease inhibitor (PI)-resistant HIV-1 protease (IC50: 0.23-0.32 microM). Kinetic and biochemical assays confirmed that P27 inhibits protease dimerization. Fluorescein-labeled peptide accumulated in MT-2 cells and protected acutely infected MT-2 cells from HIV-1-induced cytotoxicity (IC50: 5.1 microM). P27 also inhibited p24 accumulation from H9 and U937 cells chronically infected with WT or PI-resistant HIV-1. Immunoblot analysis on the supernatants and infected cells revealed a block in virus release by P27 rather than an inhibition of polyprotein processing. However, inhibition of p55 Gag processing by active-site inhibitors was enhanced when combined with P27, suggesting that P27 can affect protease function in maturing virions. Although P27 was rationally designed to block dimerization of the mature HIV-1 protease, the effects of P27 on HIV-1 replication may be related to partial inhibition of Gag-Pol processing leading to a disruption in virus release.
Similar articles
-
Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.Virology. 2002 Jan 5;292(1):137-49. doi: 10.1006/viro.2001.1184. Virology. 2002. PMID: 11878916
-
Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.J Virol. 2000 May;74(10):4621-33. doi: 10.1128/jvi.74.10.4621-4633.2000. J Virol. 2000. PMID: 10775598 Free PMC article.
-
Blocking of human immunodeficiency virus type-1 virion autolysis by autologous p2(gag) peptide.J Biochem. 2004 Mar;135(3):447-53. doi: 10.1093/jb/mvh052. J Biochem. 2004. PMID: 15113844
-
HIV-1 evolution under pressure of protease inhibitors: climbing the stairs of viral fitness.J Biomed Sci. 1999 Sep-Oct;6(5):298-305. doi: 10.1007/BF02253518. J Biomed Sci. 1999. PMID: 10494036 Review.
-
Proteolytic events of HIV-1 replication as targets for therapeutic intervention.Curr Pharm Des. 2003;9(22):1803-15. doi: 10.2174/1381612033454478. Curr Pharm Des. 2003. PMID: 12871198 Review.
Cited by
-
Activity of human immunodeficiency virus type 1 protease inhibitors against the initial autocleavage in Gag-Pol polyprotein processing.Antimicrob Agents Chemother. 2012 Jul;56(7):3620-8. doi: 10.1128/AAC.00055-12. Epub 2012 Apr 16. Antimicrob Agents Chemother. 2012. PMID: 22508308 Free PMC article.
-
Toward eradicating HIV reservoirs in the brain: inhibiting P-glycoprotein at the blood-brain barrier with prodrug abacavir dimers.J Am Chem Soc. 2012 Feb 15;134(6):2976-80. doi: 10.1021/ja206867t. Epub 2011 Sep 9. J Am Chem Soc. 2012. PMID: 21866921 Free PMC article.
-
Current and Novel Inhibitors of HIV Protease.Viruses. 2009 Dec;1(3):1209-39. doi: 10.3390/v1031209. Epub 2009 Dec 11. Viruses. 2009. PMID: 21994591 Free PMC article.
-
Flexible catalytic site conformations implicated in modulation of HIV-1 protease autoprocessing reactions.Retrovirology. 2011 Oct 10;8:79. doi: 10.1186/1742-4690-8-79. Retrovirology. 2011. PMID: 21985091 Free PMC article.
-
Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS.J Med Chem. 2016 Jun 9;59(11):5172-208. doi: 10.1021/acs.jmedchem.5b01697. Epub 2016 Jan 22. J Med Chem. 2016. PMID: 26799988 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous